eighth meeting parties decided dec viii parties operating article request companies applying mdi essential use exemptions demonstrate ongoing research development alternatives cfc mdis due diligence and or collaborate companies efforts and future request report confidence nominating party whether extent resources deployed end progress made research development licence applications submitted health authorities non cfc alternatives parties operating article request companies applying mdi essential use exemptions demonstrate undertaking individual collaborative industry efforts consultation medical community educate health care professionals patients treatment options transition non cfc alternatives parties operating article request companies applying mdi essential use exemptions demonstrate they companies distributing selling product differentiating packaging company non cfc mdis cfc mdis applying appropriate marketing strategies consultation medical community encourage doctor patient acceptance company non cfc alternatives subject health product safety considerations parties operating article request companies manufacturing distributing selling cfc mdis non cfc alternatives engage false misleading advertising targeted non cfc alternatives cfc mdis parties operating article request companies applying mdi essential use exemptions ensure participation regulatory proceedings conducted view toward legitimate environmental health safety concerns parties operating article request companies manufacturing cfc mdis take economically feasible steps minimize cfc emissions manufacture mdis parties operating article request companies manufacturing distributing selling cfc mdis dispose expired defective returned mdis containing cfcs manner minimizes cfc emissions parties operating article request companies manufacturing cfc mdis review annually cfc requirements current mdi market forecasts notify national regulatory authorities forecasts result surplus cfcs obtained essential use exemptions parties operating article request companies applying mdi essential use exemptions provide information steps taken provide continuity supply asthma chronic obstructive pulmonary disease copd treatments including cfc mdis importing countries parties operating article request companies applying mdi essential use exemptions provide information demonstrates steps taken assist company mdi manufacturing facilities parties operating article countries economies transition upgrading technology capital equipment needed manufacturing non cfc asthma chronic obstructive pulmonary disease copd treatments request technology economic assessment panel reflect paragraphs revised version handbook essential use nominations